Regulators of G protein signaling & drugs of abuse
- PMID: 15734717
- DOI: 10.1124/mi.5.1.7
Regulators of G protein signaling & drugs of abuse
Abstract
Drugs of abuse such as opioids and stimulants share a common dopaminergic reward pathway; however, in response to continual intermittent exposure to such drugs, there are neuronal alterations leading to changes in behavior. Regulators of G protein signaling (RGS) are proteins that negatively regulate G protein signaling and are expressed in brain areas important for the pharmacology of abused drugs. Moreover, the level of expression of several of these proteins is regulated by abused drugs. In this article, we discuss RGS proteins, their regulation by morphine and stimulants, and how altered levels of these proteins affect cell signaling to contribute to the pharmacology and behavioral consequence of abused drugs. Finally, we consider if RGS proteins represent viable targets for drug abuse medications.
Similar articles
-
Regulator of G protein-signaling proteins and addictive drugs.Ann N Y Acad Sci. 2010 Feb;1187:341-52. doi: 10.1111/j.1749-6632.2009.05150.x. Ann N Y Acad Sci. 2010. PMID: 20201861 Review.
-
In situ hybridization analysis of RGS mRNA regulation and behavioral phenotyping of RGS mutant mice.Methods Enzymol. 2004;389:205-29. doi: 10.1016/S0076-6879(04)89013-X. Methods Enzymol. 2004. PMID: 15313568 Review.
-
Multi-tasking RGS proteins in the heart: the next therapeutic target?Circ Res. 2005 Mar 4;96(4):401-11. doi: 10.1161/01.RES.0000158287.49872.4e. Circ Res. 2005. PMID: 15746448 Review.
-
Uncoupling between noradrenergic and serotonergic neurons as a molecular basis of stable changes in behavior induced by repeated drugs of abuse.Biochem Pharmacol. 2008 Jan 1;75(1):85-97. doi: 10.1016/j.bcp.2007.06.038. Epub 2007 Jun 30. Biochem Pharmacol. 2008. PMID: 17686465 Review.
-
[The structure, classification and function of RGS proteins].Sheng Li Ke Xue Jin Zhan. 2005 Jul;36(3):215-9. Sheng Li Ke Xue Jin Zhan. 2005. PMID: 16270819 Review. Chinese.
Cited by
-
Striatal phosphodiesterase 10A availability is altered secondary to chronic changes in dopamine neurotransmission.EJNMMI Radiopharm Chem. 2017;1(1):3. doi: 10.1186/s41181-016-0005-5. Epub 2016 Mar 21. EJNMMI Radiopharm Chem. 2017. PMID: 29564380 Free PMC article.
-
Regulator of G protein signaling 4 inhibits human melanoma cells proliferation and invasion through the PI3K/AKT signaling pathway.Oncotarget. 2017 Sep 11;8(45):78530-78544. doi: 10.18632/oncotarget.20825. eCollection 2017 Oct 3. Oncotarget. 2017. PMID: 29108247 Free PMC article.
-
Regulators of G Protein Signaling in Analgesia and Addiction.Mol Pharmacol. 2020 Dec;98(6):739-750. doi: 10.1124/mol.119.119206. Epub 2020 May 30. Mol Pharmacol. 2020. PMID: 32474445 Free PMC article. Review.
-
R9AP and R7BP: traffic cops for the RGS7 family in phototransduction and neuronal GPCR signaling.Trends Pharmacol Sci. 2009 Jan;30(1):17-24. doi: 10.1016/j.tips.2008.10.002. Epub 2008 Nov 29. Trends Pharmacol Sci. 2009. PMID: 19042037 Free PMC article. Review.
-
Regulator of G-Protein Signaling (RGS) Protein Modulation of Opioid Receptor Signaling as a Potential Target for Pain Management.Front Mol Neurosci. 2020 Jan 24;13:5. doi: 10.3389/fnmol.2020.00005. eCollection 2020. Front Mol Neurosci. 2020. PMID: 32038168 Free PMC article. Review.